Current Hypoglycemia News and Events

Current Hypoglycemia News and Events, Hypoglycemia News Articles.
Sort By: Most Relevant | Most Viewed
Page 1 of 9 | 331 Results
Wearable sensor monitors health, administers drugs using saliva and tears
A new kind of wearable health device would deliver real-time medical data to those with eye or mouth diseases, according to Huanyu 'Larry' Cheng, Dorothy Quiggle Career Development Professor in the Penn State Department of Engineering Science and Mechanics (ESM). (2021-02-01)

ADA lowers target HbA1C levels for children with type-1 diabetes
In early 2020, upon recommendation by leading endocrinologists, American Diabetes Association lowered the target hemoglobin A1C guidelines for children with type 1 diabetes. Their goal in recommending stricter glucose control was to ensure children with type 1 diabetes have better immediate and long-term health outcomes with fewer health complications and reduced mortality rates. In this ''Perspective'' article they discuss the evidence and rationale behind this new recommendation. (2021-01-14)

'Artificial Pancreas Dashboard' to standardize hybrid closed-loop reporting
A standardized ''Artificial Pancreas (AP) Dashboard'' should provide easy to use single-page hybrid closed-loop system (HCL) reporting for insulin requiring patients with diabetes. The AP Dashboard will help standardize HCL reporting similar to standardized CGM reporting and an electrocardiogram (EKG) and will be likely to help improve glycemic control and reduce hypoglycemia. (2020-12-01)

Diabetes drug can treat and reverse heart failure and reduce
Mount Sinai clinical trial results could help lead to FDA approval (2020-11-13)

Novel therapy approach for hyperinsulinemic hypoglycemia
A new method to treat hyperinsulinemic hypoglycemia has proven highly selective in targeting lesions and effective in slowing tumor growth, according to research published in the November issue of the Journal of Nuclear Medicine. (2020-11-08)

15-year trend persists in disparate insulin pump use in children
Insulin pumps are widely used in the management of type 1 diabetes (T1D) and reviews have shown insulin pump therapy to be associated with improved glycemic control, fewer severe hypoglycemia events, and improved quality of life. Yet, non-Hispanic white children (NHW) are more than twice as likely as non-Hispanic Black children (NHB) to use this technology. (2020-10-01)

Artificial pancreas can prevent dangerously low blood sugar in people with T1D
A new artificial pancreas system can prevent hypoglycemia--episodes of dangerously low blood sugar--during and after heavy exercise in people with type 1 diabetes, according to a small study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism. (2020-08-27)

UVA-developed artificial pancreas effective for children ages 6-13, study finds
An artificial pancreas originally developed at the University of Virginia Center for Diabetes Technology safely and effectively manages blood sugar levels in children ages 6 to 13 with type 1 diabetes, a national clinical trial has found. Data from this and other studies has prompted the U.S. Food and Drug Administration to approve the device for use by children ages 6 and older. (2020-08-27)

Artificial pancreas effectively controls type 1 diabetes in children age 6 and up
A clinical trial at four pediatric diabetes centers in the United States has found that a new artificial pancreas system -- which automatically monitors and regulates blood glucose levels -- is safe and effective at managing blood glucose levels in children as young as age six with type 1 diabetes. The trial was funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health. (2020-08-26)

Continuous glucose monitoring reduces hypoglycemia in older adults with type 1 diabetes
Laura Young, MD, PhD, associate professor of medicine, was UNC's principal investigator for this six-month clinical trial that shows the use of continuous glucose monitoring (CGM) reduces serious levels of hypoglycemia compared with standard monitoring by daily use of blood glucose finger-stick test strips. (2020-06-16)

New algorithm uses artificial intelligence to help manage type 1 diabetes
Researchers and physicians at Oregon Health & Science University have designed a method to help people with type 1 diabetes better manage their glucose levels. The method relies upon artificial intelligence and automated monitoring. (2020-06-12)

New data show Abbott's FreeStyle® Libre 14 day system significantly reduces costs associated with diabetes management and complications
New data show Abbott's freestyle® libre 14 day system significantly reduces costs associated with diabetes management and complications (2020-06-05)

People with Type 1 diabetes spend $2,500 a year in health care costs
Adults and children with type 1 diabetes will spend an average of $2,500 a year out-of-pocket for health care -- but insulin isn't always the biggest expense -- new research suggests. (2020-06-01)

First-of-its-kind-study reveals that eating prior to cardiac catheterization is non-inferior to fast
Patients undergoing cardiac catheterization are traditionally instructed to follow nothing by mouth, or nil per os (NPO), as there are no current standardized fasting protocols. The single center, randomized study presented today as late-breaking science during the SCAI 2020 Scientific Sessions Virtual Conference aimed to compare safety and clinical outcomes of a non-fasting (NF) strategy as compared to current standard fasting (SF) protocol. (2020-05-14)

Researchers identify unique glucose-sensing neurons that regulate blood sugar
At Baylor College of Medicine and other institutions, researchers have identified a group of unique glucose-sensing neurons in the brain and how they work together to prevent severe hypoglycemia in mice. (2020-05-01)

People with type 2 diabetes and heart disease may benefit from newer therapies
Coronary artery disease among people with type 2 diabetes may need to be treated more aggressively than in people with coronary artery disease who do not have diabetes. A new American Heart Association scientific statement summarizes the simultaneous management of both diabetes and coronary artery disease and details medications, procedures and lifestyle modifications that may reduce the risk of heart attack and complications among people with both conditions. (2020-04-13)

Potential harms of chloroquine, hydroxychloroquine and azithromycin for treating COVID-19
Chloroquine, hydroxychloroquine and azithromycin are being used to treat and prevent COVID-19 despite weak evidence for effectiveness, and physicians and patients should be aware of the drugs' potentially serious adverse events, states a review in CMAJ (Canadian Medical Association Journal). (2020-04-08)

Getting off of the blood sugar roller coaster
For the 250,000 Canadians living with type 1 diabetes, the days of desperately trying to keep their blood sugar stable are coming to an end. A team of researchers at McGill University's Faculty of Medicine is working to optimize an artificial pancreas with the ability to minimize the glucose highs and lows that diminish quality of life and contribute to long-term health complications. (2020-02-27)

The potentially deadly paradox of diabetes management
Diabetes affects nearly 1 in 10 adults in the US, of these millions, more than 90% have Type 2 diabetes. Controlling blood sugar and glycosylated hemoglobin levels -- or HbA1c, which is sometimes referred to as A1C -- is key to diabetes management and necessary to prevent its immediate and long-term complications. However, new Mayo Clinic research shows that diabetes management may be dangerously misaligned. (2020-02-19)

Seurat therapeutics announces novel mechanisms from rat migraine model of intranasal IGF-1
Studies demonstrated intranasal Insulin-like Growth Factor-1 (IGF-1) safely and effectively dampens activation of the trigeminal system pain pathway in rats, a known site of pain origin in migraine headaches The results support further development of nasal IGF-1 as a novel treatment for migraines, which afflict 39 million people in the USA. (2020-02-10)

Understanding unexplained low blood sugar in children: More than normal variation
Idiopathic ketotic hypoglycemia (IKH) is often relatively mild and may remain undiagnosed. Luckily it often disappears with age. But severe variants, sometimes affecting several family members, have prompted the research team at the Complex Hypoglycemia Center, Odense University Hospital, Denmark, to dive more deeply into potential new genetic explanations for this disease. -We have identified four novel genes that appear to explain the IKH in at least four families, researchers say. (2020-02-07)

New closed-loop system offers promise as novel treatment for post-bariatric hypoglycemia
Post-bariatric hypoglycemia is a profoundly life-altering condition for patients. Having unpredictable hypoglycemia that people can't detect is really an unsafe situation. Researchers at Joslin Diabetes Center and Harvard John A. Paulson School of Engineering and Applied Sciences have developed a closed-loop system that automatically provides patients with an appropriate, as-needed dose of liquid glucagon to treat this condition. (2020-01-09)

First-ever quality measures aim to reduce diabetes complications
The Endocrine Society and Avalere Health introduced the first-ever quality measures to help healthcare providers assess how well they identify and care for older adults at greater risk of hypoglycemia -- low blood sugar that can be a dangerous complication of diabetes treatment. (2019-12-12)

Pot while pregnant: UNLV medicine doctors urge caution
Daily marijuana use during pregnancy may lead to an increased risk of low birth weight, low resistance to infection, decreased oxygen levels and other negative fetal health outcomes, according to a new study from a team of UNLV Medicine doctors. (2019-12-02)

New machine learning algorithms offer safety and fairness guarantees
Writing in Science, Thomas and his colleagues Yuriy Brun, Andrew Barto and graduate student Stephen Giguere at UMass Amherst, Bruno Castro da Silva at the Federal University of Rio Grande del Sol, Brazil, and Emma Brunskill at Stanford University this week introduce a new framework for designing machine learning algorithms that make it easier for users of the algorithm to specify safety and fairness constraints. (2019-11-21)

Adding weight loss counseling to group visits improves diabetes outcomes
For people with difficult-to-control diabetes, adding intensive weight management counseling to group medical visits provided extra health benefits beyond improved blood-sugar control, according to a study led by researchers at the Duke Diet & Fitness Center and the Department of Veterans Affairs. (2019-11-04)

Discontinuing insulin for older adults with type 2 diabetes
Patients with type 2 diabetes who were in poor health were more likely to continue taking insulin after age 75 than their counterparts in better health, according to Kaiser Permanente research published today in JAMA Internal Medicine. As people with type 2 diabetes age, the risks of insulin use can outweigh its benefits, creating the need for increased provider and patient education. (2019-09-23)

Meal type and size are the key factors affecting carb-counting in type 1 diabetes
Meal type and size are the most important factors influencing the accuracy of carb-counting for the control of blood sugar in type 1 diabetes, according to new research being presented at this year's European Association for the Study of Diabetes (EASD) Annual Meeting in Barcelona, Spain (Sept. 16-20). (2019-09-16)

Popular pain medication associated with greater risk of hypoglycemia
As the opioid tramadol has grown in popularity so too have documented cases of adverse effects. In a new study, researchers at Skaggs School of Pharmacy and Pharmaceutical Sciences at UC San Diego show that patients who take tramadol are at greater risk for hypoglycemia, abnormally low blood sugar. (2019-08-28)

College students with diabetes at risk for complications, depression, low quality of life
The study surveyed 173 people with type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM), who worked at or attended a university. High levels of diabetes distress were reported by 27% of those with T1DM and 30% of those with T2DM. Participants who reported high diabetes distress also indicated a lower diabetes quality of life. Researchers found 19% of those with T1DM and 17% of those with T2DM screened positive for severe depression. (2019-08-26)

Too much of a good thing can be dangerous, finds researchers investigating hypoglycemia
For people with diabetes, taking medications and monitoring their blood sugar is part of the rhythm of their daily lives. However, according to new research from Mayo Clinic, more than 20% of adult patients in the US are likely treated too intensively. This has caused thousands of potentially preventable emergency department visits and hospitalizations for hypoglycemia (low blood sugar). (2019-08-15)

Researchers create model to predict risk of low blood sugar in people with diabetes
A new study by researchers from Regenstrief Institute and Merck identifies the risk factors that could help healthcare providers recognize patients being treated for diabetes who are most likely to have low blood sugar. Many patients with diabetes, especially those with recurring episodes of low blood sugar, are unaware when it occurs, despite the risk of serious adverse events including cognitive impairment, coma and death. (2019-07-25)

Feinstein Institutes discovery may have implications for diabetes management and therapy
Feinstein Institutes discovery may have implications for diabetes management and therapy. (2019-07-10)

Long-term islet transplant recipients show near-normal glucose control
Findings from continuous glucose monitoring evaluations in islet transplant recipients who have been insulin independent for an average of 10 years show near normal glycemic profiles and time-in-range metrics, demonstrating that islet transplantation can be a successful long-term therapy for select patients with type 1 diabetes. (2019-06-08)

'Smart' insulin could prevent hypoglycemia during diabetes treatment
UCLA bioengineers and their colleagues have developed a new type of insulin that could help prevent hypoglycemia in people who use the drug to manage diabetes. (2019-05-16)

Patients with diabetes are 40% more likely to be readmitted to the hospital
Patients with diabetes and low blood glucose have higher rates of death following hospital discharge, according to a study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism. (2019-05-01)

New hope for preventing dangerous diabetes complication
People with diabetes who use insulin to control their blood sugar can experience a dangerous condition called hypoglycemia when blood sugar levels fall too low. New insights into a recently discovered protein called neuronostatin could lead to new ways to treat and prevent hypoglycemia, which is sometimes deadly for people with diabetes. (2019-04-06)

Automated drug delivery system combats low blood sugar after weight-loss surgery
A new automated drug delivery system can help prevent dangerously low blood sugar in patients who have undergone weight-loss surgery, according to a study to be presented Monday, March 25, at ENDO 2019, the Endocrine Society's annual meeting in New Orleans, La. (2019-03-25)

Older adults with type 1 diabetes often not aware of hypoglycemia
Older adults with type 1 diabetes typically have low blood sugar, or hypoglycemia, for more than an hour a day, suggests research to be presented Monday, March 25, at ENDO 2019, the annual meeting of the Endocrine Society, in New Orleans, La. (2019-03-23)

Treating diabetes in older adults requires simpler medication regimens, looser glycemic targets
Simplifying medication regimens and tailoring glycemic targets in older adults with diabetes improves adherence and avoids treatment-related complications, according to a Clinical Practice Guideline issued today by the Endocrine Society. The Society debuted the guideline during a press conference on the opening day of ENDO 2019, its annual meeting in New Orleans, La. (2019-03-23)

Page 1 of 9 | 331 Results
   First   Previous   Next      Last   
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.